Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study) (vol 10, e0145468, 2015)

被引：0
|
作者：
Izumi, Keisuke
Kaneko, Yuko
Hashizume, Misato
Yoshimoto, Keiko
Takeuchi, Tsutomu
机构：
来源：
PLOS ONE | 2016年 / 11卷 / 03期
关键词：
D O I：
10.1371/journal.pone.0152341
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 4 条
  • [1] Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
    Izumi, Keisuke
    Kaneko, Yuko
    Hashizume, Misato
    Yoshimoto, Keiko
    Takeuchi, Tsutomu
    PLOS ONE, 2015, 10 (12):
  • [2] BASELINE OSTEOPONTIN LEVELS PREDICT THE CLINICAL EFFICACY OF TOCILIZUMAB NOT INFLIXIMAB IN BIO-NAIVE RHEUMATOID ARTHRITIS PATIENTS: THE KEIO FIRST BIO COHORT AT 1 YEAR
    Izumi, K.
    Kaneko, Y.
    Hashizume, M.
    Nishina, N.
    Kikuchi, J.
    Yoshimoto, K.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 384 - 384
  • [3] SERUM GM-CSF LEVELS ARE SIGNIFICANTLY ASSOCIATED WITH INTERSTITIAL PNEUMONIA IN BIOLOGIC-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: A SINGLE-CENTER PROSPECTIVE COHORT STUDY (KEIO FIRST-BIO COHORT STUDY)
    Izumi, K.
    Hashizume, M.
    Yoshimoto, K.
    Kaneko, Y.
    Yasuoka, H.
    Suzuki, K.
    Yamaoka, K.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1013 - 1013
  • [4] Circulating Monocyte Count Is Significantly Associated with Interstitial Pneumonia in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Cohort Study (Keio First-Bio Cohort Study)
    Izumi, Keisuke
    Hashizume, Misato
    Kaneko, Yuko
    Yoshimoto, Keiko
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
1